Press release
Prominent Interstitial Lung Disease Market Trend for 2025: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment
Interstitial Lung Disease Market Trends
The interstitial lung disease market is expected to grow from $1.97 billion in 2024 to $2.11 billion in 2025, at a CAGR of 7.2%. Growth drivers include improved awareness and diagnosis, immune system modulation therapies, respiratory rehabilitation programs, and multidisciplinary care teams.
The Interstitial Lung Disease market will grow to $2.85 billion by 2029 at a CAGR of 7.9%, driven by precision medicine, novel drug development, regenerative medicine, and telehealth. Trends include imaging advancements, AI in imaging, and fibrosis subtype differentiation.
What Is Driving the Growth Trajectory of the Interstitial Lung Disease Market?
The increasing prevalence of allergic conditions is expected to drive the growth of the interstitial lung disease market. Allergic reactions occur when the immune system overreacts to substances that are typically harmless. These reactions may lead to interstitial lung disease (ILD), especially hypersensitivity pneumonitis, which is an allergic response that affects the lungs. For instance, in November 2023, the National Asthma Council revealed that 467 asthma-related deaths were recorded in 2022 in Australia, up from 355 in 2021. This highlights the rising prevalence of allergic diseases, which is driving the growth of the interstitial lung disease market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13019&type=smp
Which Leading Companies Are Shaping the Growth of the Interstitial Lung Disease Market?
Major companies operating in the interstitial lung disease market are Roche Laboratories Inc., Merck & Co. Inc., Bayer AG, Novartis Pharmaceuticals Corporation, The Bristol-Myers Squibb Company, Amgen Inc., Boehringer Ingelheim, Siemens Healthineers, Koninklijke Philips N.V., Teva Pharmaceuticals USA Inc., AstraZeneca PLC, Horizon Pharma USA Inc., Genentech Inc., Amneal Pharmaceuticals LLC, Fujirebio Diagnostics Inc., Insmed Inc., VIDA Diagnostics Inc., EmphyCorp Inc., Verseau Therapeutics, Regend Therapeutics Co., LTT Bio-Pharma Co. Ltd., Galecto Biotech, Pulmatrix Inc., PureTech Health PLC, Pneuma Respiratory Inc., Bellerophon Therapeutics Inc., MediciNova Inc., Altavant Sciences Inc., Verona Pharma plc.
How Is the Interstitial Lung Disease Market Evolving?
Major companies in the interstitial lung disease market are emphasizing product launches, particularly innovative therapies for conditions such as idiopathic pulmonary fibrosis (IPF). IPF is a chronic, progressive lung disease characterized by lung tissue scarring, leading to breathing difficulties and reduced oxygen exchange. For example, in February 2024, C.H. Boehringer Sohn AG & Co. KG, a Germany-based biopharmaceutical company, secured FDA approval for BI 1015550, a therapy designed for IPF treatment. BI 1015550 is an investigational oral drug that inhibits phosphodiesterase 4B (PDE4B), offering antifibrotic and anti-inflammatory benefits aimed at slowing lung function decline in patients with IPF.
What Are the Key Segments of the Interstitial Lung Disease Market?
The interstitial lung disease market covered in this report is segmented -
1) By Drug Type: Oral Corticosteroids, Immune Suppressing, Anti-Fibrotic Medication, Other Drugs
2) By Disease Type: Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonitis, Hypersensitivity Pneumonitis, Cryptogenic Organizing Pneumonia (COP), Sarcoidosis, Acute Interstitial Pneumonitis
3) By Application: Adults, Children
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Oral Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone
2) By Immune Suppressing: Azathioprine, Methotrexate, Mycophenolate Mofetil
3) By Anti-Fibrotic Medication: Pirfenidone, Nintedanib
4) By Other Drugs: Antioxidants, Anticoagulants, Other Novel Therapies
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report
Which Region Dominates the Interstitial Lung Disease Market?
North America was the largest region in the interstitial lung disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interstitial lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Interstitial Lung Disease Global Market Report?
- Market Size Analysis: Analyze the Interstitial Lung Disease Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Interstitial Lung Disease Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Interstitial Lung Disease Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Interstitial Lung Disease Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prominent Interstitial Lung Disease Market Trend for 2025: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment here
News-ID: 3850612 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Interstitial
Prominent Interstitial Cystitis Market Trend for 2025: Advancements in Interstit …
How Are the key drivers contributing to the expansion of the interstitial cystitis market?
The increasing occurrence of urinary tract infections is anticipated to fuel the expansion of the interstitial cystitis market. Urinary tract infections are bacterial infections that can materialize at any point in the urinary system, resulting from bacteria that infiltrate the urethra. These infections could directly or indirectly bring about bacterial cystitis, and lack of treatment can lead…
Shaping the Interstitial Cystitis Market in 2025: Advancements in Interstitial C …
How Big Is the Interstitial Cystitis Market Expected to Be, and What Will Its Growth Rate Be?
The interstitial cystitis market is projected to grow from $1.83 billion in 2024 to $1.98 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%. This growth is attributed to advancements in diagnosis, increased awareness and education, pharmaceutical developments, and supportive therapies.
The Interstitial Cystitis market will grow to $2.78 billion by 2029…
Interstitial lung disease Pipeline involves 120+ key companies continuously work …
DelveInsight's, "Interstitial Lung Diseases Pipeline Insight, 2022," report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in the Interstitial Lung Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Interstitial Lung Disease…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
Interstitial Lung Disease Therapeutics - Pipeline Analysis 2018
Interstitial lung disease is a type of inflammatory disease that affects and thickens the interstitium of the lungs.
Download the sample report @ https://www.pharmaproff.com/request-sample/1126
The interstitium is a lace like network of the tissue that provide support to the air sacs and the capillaries in the interstitium which allows the gas exchange between the blood and alveolar tissues.
Get the detailed analysis @ https://www.pharmaproff.com/report/interstitial-lung-disease-therapeutics-pipeline-analysis
Some of the types of the condition include…
Interstitial Cystitis-Pipeline Review H2 2018
Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome)-Pipeline Review, H2 2018
Summary
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome)-Pipeline Review, H2 2018, provides an overview of the Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous System) pipeline landscape.
Interstitial cystitis also called painful bladder syndrome is a chronic condition in which person experience bladder pressure, bladder pain and sometimes pelvic pain, ranging from mild discomfort…
